MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Proceeds fromconvertible notes$14,200,000 Proceeds from exercise ofwarrants$1,000 Net cash provided byfinancing activities$9,168,360 Canceled cashflow$5,032,640 Net change in cashand cash...$2,413,802 Canceled cashflow$6,754,558 Repayment of term loan$2,104,557 Repayment of revolvingline of credit$1,643,923 Equity issuance costs$1,157,500 Repayment of merchant cashadvance$89,909 Repayment of promissorynote$36,751 Loss onextinguishment of debt-$8,881,694 Accrued expenses andother liabilities$2,640,868 Stock-based compensation$2,562,514 Accounts payable$2,432,030 Amortization of debt discount$2,343,252 Loss on contracttermination fee-$766,394 Amortization$657,924 Allowances for creditlosses$213,787 Reserve for inventoryobsolescence$72,967 Loss onextinguishment on vendor...-$60,120 Inventories, net-$56,336 Depreciation$55,497 Net cash used inoperating activities-$6,307,328 Net cash used ininvesting activities-$447,230 Canceled cashflow$20,743,383 Net loss-$26,105,822 Investments in capitalizedsoftware$447,230 Prepaid and othercurrent assets$410,010 Due from / to relatedparties, net$251,068 Accounts receivable, net$250,904 Operating leaseliabilities, net-$32,906 Net revenues$3,339,423 Net loss beforeincome taxes-$26,105,822 Gross profit$352,425 Other income$609,897 Canceled cashflow$2,986,998 Loss from operations-$13,360,592 Total other expense,net-$12,745,230 Canceled cashflow$352,425 Canceled cashflow$609,897 Cost of net revenues$2,986,998 Total operatingexpenses$13,713,017 Loss onextinguishment of debt-$8,881,694 Interest expense, net$3,633,919 Loss on contracttermination fee-$766,394 Loss onextinguishment of vendor...-$60,120 Settlement fees$13,000 General andadministrative$11,925,606 Sales and marketing$1,073,990 Depreciation andamortization$713,421
Cash Flow

DataMeds AI, Inc. (MEDS)

DataMeds AI, Inc. (MEDS)

source: myfinsight.com